Viewing Study NCT01491503


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-28 @ 11:20 AM
Study NCT ID: NCT01491503
Status: COMPLETED
Last Update Posted: 2013-04-05
First Post: 2011-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Drug Interaction Study of Montelukast and Levocetirizine
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:

Study Overview

Official Title: Open Label, Randomized, 6-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Montelukast Sodium and Levocetirizine Dihydrochloride in Health Male Volunteers
Status: COMPLETED
Status Verified Date: 2013-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MOLZ
Brief Summary: The purpose of this study is to evaluate the drug-drug interaction between montelukast sodium and levocetirizine dihydrochloride in healthy male volunteers.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: